Leptospira interrogans serogroup Canicola antigens (L. interrogans serogroup Canicola antigens)

Leptospira interrogans serogroup Canicola antigens represent a diverse group of immunogenic molecules, primarily including lipopolysaccharides (LPS) and various outer membrane proteins (OMPs) such as LipL32, LipL41, and Lig proteins [1.4.4]. These antigens are critical for the pathogenesis of Leptospira interrogans, facilitating adhesion to host cells and enabling the bacteria to evade host immune defenses [1.4.2]. In clinical medicine, these antigens are the primary targets for diagnostic assays, such as the Microscopic Agglutination Test (MAT), and for the development of vaccines aimed at preventing leptospirosis [1.1.3, 1.3.1]. Vaccines utilizing these antigens, often in the form of inactivated whole-cell bacterins, stimulate the production of serovar-specific antibodies that provide protective immunity against infection [1.1.4]. However, the high degree of antigenic variation among different serogroups necessitates the inclusion of multiple serovar-specific antigens in vaccine formulations to ensure broad protection [1.4.5]. Therapeutic challenges include the relatively short duration of vaccine-induced immunity and the potential for vaccinated individuals to remain asymptomatic carriers that shed the pathogen in their urine [1.1.1, 1.1.4].

Other names

Canicola antigensLeptospira Canicola antigensSerovar-specific main antigenTM antigenLeptospira interrogans serovar Canicola antigens

Induction of active immunity through the stimulation of B-lymphocytes to produce serovar-specific neutralizing antibodies and the activation of T-cell mediated immune responses against Leptospira interrogans serogroup Canicola.